Key result
Argemone oil poisoning linked to myocardial involvement in ~100% of cases.
Why the study?
Cardiovascular manifestations in argemone oil poisoning have not been systematically studied to characterize myocardial involvement and related clinical features.
Observational (n=11)
Argemone oil poisoning causes minor nonspecific myocarditis and prominent symptoms mimicking heart failure, which are primarily driven by capillary dilatation.
Apparent HF symptoms in argemone oil poisoning likely reflect capillary dilatation; case reports leave open whether targeted cardiac evaluation changes management.
Cardiovascular manifestations have been studied in 11 patients with argemone oil poisoning. Tachycardia, alterations in the heart sounds, cardiac enlargement, or electrocardiographic and ballistocardiographic changes indicated myocardial involvement in every case. The latter was suggestive of a nonspecific type of myocarditis and was considered to be of a minor nature. The prominent manifestations included dyspnea, edema, hepatic enlargement, and pulmonary congestion. The last 3 were probably due to capillary dilatation, whereas the cause of dyspnea was uncertain. These manifestations suggested the presence of cardiac failure, which, however, was considered unlikely except in 1 case.
No takes yet. Share an insight, caveat, or question.
Sanghvi et al. (1960) conducted an observational in Argemone oil poisoning (Epidemic Dropsy) (n=11). Argemone oil poisoning was evaluated on Myocardial involvement. Argemone oil poisoning was associated with myocardial involvement in 100% of cases (11/11), presenting with tachycardia, altered heart sounds, cardiac enlargement, or electrocardiographic changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: